Stryker (SYK) Financials

Stryker logo
$310.30 +0.66 (+0.21%)
Closing price 03:59 PM Eastern
Extended Trading
$313.18 +2.88 (+0.93%)
As of 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Stryker

Annual Income Statements for Stryker

This table shows Stryker's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993 3,246
Consolidated Net Income / (Loss)
1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993 3,246
Net Income / (Loss) Continuing Operations
1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993 3,246
Total Pre-Tax Income
1,735 1,921 2,063 2,356 2,562 1,954 2,281 2,683 3,673 3,492 4,514
Total Operating Income
1,861 2,175 2,297 2,537 2,713 2,223 2,584 2,841 3,888 3,689 4,889
Total Gross Profit
6,602 7,504 8,180 8,938 9,696 9,057 10,968 11,578 13,058 14,440 16,065
Total Revenue
9,946 11,325 12,444 13,601 14,884 14,351 17,108 18,449 20,498 22,595 25,116
Operating Revenue
9,946 11,325 12,444 13,601 14,884 14,351 17,108 18,449 20,498 22,595 25,116
Total Cost of Revenue
3,344 3,821 4,264 4,663 5,188 5,294 6,140 6,871 7,440 8,155 9,051
Operating Cost of Revenue
3,344 3,821 4,264 4,663 5,188 5,294 6,140 6,871 7,440 8,155 9,051
Total Operating Expenses
4,741 5,329 5,883 6,401 6,983 6,834 8,384 8,737 9,170 10,751 11,176
Selling, General & Admin Expense
3,610 4,137 4,552 5,099 5,356 5,361 6,427 6,386 7,111 7,685 8,651
Research & Development Expense
625 715 787 862 971 984 1,235 1,454 1,388 1,466 1,623
Amortization Expense
210 319 371 417 464 472 619 627 635 623 732
Impairment Charge
- - - - - 0.00 0.00 270 36 977 170
Total Other Income / (Expense), net
-126 -254 -234 -181 -151 -269 -303 -158 -215 -197 -375
Interest Expense
- - - - - - - - 363 409 607
Other Income / (Expense), net
-126 -254 -234 -181 -151 -269 -303 -158 148 212 232
Income Tax Expense
296 274 1,043 -1,197 479 355 287 325 508 499 1,268
Basic Earnings per Share
$3.82 $4.40 $2.73 $9.50 $5.57 $4.26 $5.29 $6.23 $8.34 $7.86 $8.49
Weighted Average Basic Shares Outstanding
376.60M 374.10M 374M 374.10M 374M 375.50M 377M 378.20M 379.60M 381M 382.20M
Diluted Earnings per Share
$3.78 $4.35 $2.68 $9.34 $5.48 $4.20 $5.21 $6.17 $8.25 $7.76 $8.40
Weighted Average Diluted Shares Outstanding
380.90M 378.50M 380.10M 380.30M 379.90M 380.30M 382.30M 382.20M 383.70M 385.60M 386.50M
Weighted Average Basic & Diluted Shares Outstanding
376.70M 374.30M 373.60M 374M 374.58M 376.20M 377.54M 378.83M 380.26M 381.58M 382.69M
Cash Dividends to Common per Share
$1.42 $1.57 $1.75 $1.93 $2.14 $2.36 $2.59 $2.84 $3.05 $3.24 $3.40

Quarterly Income Statements for Stryker

This table shows Stryker's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
788 825 834 546 654 884 859 849 745 1,276 753
Consolidated Net Income / (Loss)
788 825 834 546 654 884 859 849 745 1,276 753
Net Income / (Loss) Continuing Operations
788 825 834 546 654 884 859 849 745 1,276 753
Total Pre-Tax Income
923 998 1,043 528 764 1,016 1,029 1,705 850 1,564 997
Total Operating Income
972 1,051 1,085 581 837 1,113 1,135 1,804 936 1,659 1,034
Total Gross Profit
3,333 3,416 3,517 4,174 3,744 3,841 3,852 4,628 3,810 4,498 4,248
Total Revenue
5,243 5,422 5,494 6,436 5,866 6,022 6,057 7,171 6,020 6,589 6,520
Operating Revenue
5,243 5,422 5,494 6,436 5,866 6,022 6,057 7,171 6,020 6,589 6,520
Total Cost of Revenue
1,910 2,006 1,977 2,262 2,122 2,181 2,205 2,543 2,210 2,091 2,272
Operating Cost of Revenue
1,910 2,006 1,977 2,262 2,122 2,181 2,205 2,543 2,210 2,091 2,272
Total Operating Expenses
2,361 2,365 2,432 3,593 2,907 2,728 2,717 2,824 2,874 2,839 3,214
Selling, General & Admin Expense
1,837 1,831 1,894 2,102 2,300 2,079 2,045 2,227 2,281 2,229 2,313
Research & Development Expense
368 363 377 358 405 407 410 401 413 434 433
Amortization Expense
153 155 159 156 167 187 189 189 180 175 175
Impairment Charge
3.00 16 2.00 - 35 55 73 7.00 0.00 1.00 293
Total Other Income / (Expense), net
-49 -53 -42 -53 -73 -97 -106 -99 -86 -95 -37
Interest Expense
- - - - 137 159 157 - 148 141 143
Other Income / (Expense), net
-49 -53 -42 -53 64 62 51 508 62 46 106
Income Tax Expense
135 173 209 -18 110 132 170 856 105 288 244
Basic Earnings per Share
$2.07 $2.17 $2.18 $1.44 $1.71 $2.32 $2.25 $2.21 $1.95 $3.32 $1.97
Weighted Average Basic Shares Outstanding
380.40M 381M 381.10M 381M 381.70M 382.20M 382.40M 382.20M 382.90M 383.50M 382.20M
Diluted Earnings per Share
$2.05 $2.14 $2.16 $1.41 $1.69 $2.29 $2.22 $2.20 $1.93 $3.30 $1.96
Weighted Average Diluted Shares Outstanding
385.10M 385.40M 385.60M 385.60M 386.40M 386.40M 386.70M 386.50M 386.50M 386M 384.70M
Weighted Average Basic & Diluted Shares Outstanding
380.95M 381.08M 381.22M 381.58M 382.16M 382.31M 382.42M 382.69M 383.36M 383.57M 380.69M
Cash Dividends to Common per Share
$0.80 $0.80 $0.80 - $0.84 $0.84 $0.84 - $0.88 $0.88 $0.88

Annual Cash Flow Statements for Stryker

This table details how cash moves in and out of Stryker's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
1,584 -63 -774 1,082 721 -1,394 1.00 -1,100 1,127 681 359
Net Cash From Operating Activities
981 1,915 1,559 2,610 2,191 3,277 3,263 2,624 3,711 4,242 5,044
Net Cash From Continuing Operating Activities
981 1,915 1,559 2,610 2,191 3,277 3,263 2,624 3,711 4,242 5,044
Net Income / (Loss) Continuing Operations
1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993 3,246
Consolidated Net Income / (Loss)
1,439 1,647 1,020 3,553 2,083 1,599 1,994 2,358 3,165 2,993 3,246
Depreciation Expense
187 227 271 306 314 340 371 371 393 427 461
Amortization Expense
210 319 371 417 464 472 619 627 635 623 732
Non-Cash Adjustments To Reconcile Net Income
-764 101 -218 82 225 405 583 450 241 1,252 586
Changes in Operating Assets and Liabilities, net
-91 -379 115 -1,748 -895 461 -304 -1,182 -723 -1,053 19
Net Cash From Investing Activities
1,956 -4,191 -1,613 -2,857 -1,455 -4,701 -859 -2,924 -962 -3,000 -4,866
Net Cash From Continuing Investing Activities
1,956 -4,191 -1,613 -2,857 -1,455 -4,701 -859 -2,924 -962 -3,000 -4,866
Purchase of Property, Plant & Equipment
-270 -490 -598 -572 -649 -487 -525 -588 -575 -755 -761
Acquisitions
-153 -4,332 -831 -2,451 -802 -4,222 -339 -2,563 -390 -1,628 -4,960
Divestitures
- - - - - - - - 0.00 0.00 165
Sale and/or Maturity of Investments
4,094 785 87 394 69 61 55 240 0.00 -750 750
Other Investing Activities, net
0.00 -3.00 -1.00 -2.00 1.00 1.00 -1.00 39 3.00 133 -60
Net Cash From Financing Activities
-1,223 2,258 -794 1,329 3.00 -11 -2,365 -749 -1,594 -525 113
Net Cash From Continuing Financing Activities
-1,223 2,258 -794 1,329 3.00 -11 -2,365 -749 -1,594 -525 113
Repayment of Debt
-2,266 -756 -233 -670 -1,349 -2,330 -1,306 -1,076 -1,541 -2,122 -1,433
Payment of Dividends
-521 -568 -735 -717 -778 -863 -950 -1,051 -1,139 -1,219 -1,284
Issuance of Debt
2,320 3,662 499 3,136 2,573 3,292 5.00 1,500 1,241 3,011 2,979
Other Financing Activities, net
-56 -67 -95 -120 -136 -110 -114 -122 -155 -195 -149
Effect of Exchange Rate Changes
-130 -45 74 - -18 41 -38 -51 -28 -36 68
Cash Interest Paid
101 180 231 248 286 304 325 324 356 396 582
Cash Income Taxes Paid
497 510 312 539 457 323 622 505 693 989 1,002

Quarterly Cash Flow Statements for Stryker

This table details how cash moves in and out of Stryker's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-641 -456 1,976 -198 -1,332 55 881 755 -1,133 513 -120
Net Cash From Operating Activities
204 633 1,474 1,931 250 1,111 1,540 2,143 581 1,261 1,461
Net Cash From Continuing Operating Activities
204 633 1,474 1,931 250 1,111 1,540 2,143 581 1,261 1,461
Net Income / (Loss) Continuing Operations
788 825 834 546 654 884 859 849 745 1,276 753
Consolidated Net Income / (Loss)
788 825 834 546 654 884 859 849 745 1,276 753
Depreciation Expense
107 103 109 108 105 109 120 127 120 121 120
Amortization Expense
153 155 159 156 167 187 189 189 180 175 175
Non-Cash Adjustments To Reconcile Net Income
90 71 82 1,009 153 169 196 68 87 55 360
Changes in Operating Assets and Liabilities, net
-934 -521 290 112 -829 -238 176 910 -551 -366 53
Net Cash From Investing Activities
-408 -117 -2,172 -303 -4,136 -104 -321 -305 -185 -639 -187
Net Cash From Continuing Investing Activities
-408 -117 -2,172 -303 -4,136 -104 -321 -305 -185 -639 -187
Purchase of Property, Plant & Equipment
-167 -152 -170 -266 -123 -183 -187 -268 -166 -202 -237
Acquisitions
-246 -88 -1,264 -30 -4,749 -65 -136 -10 -22 -437 -22
Purchase of Investments
-18 -14 -759 -17 -11 -16 -5.00 - -5.00 -14 -4.00
Sale and/or Maturity of Investments
23 107 9.00 9.00 767 15 8.00 -40 7.00 16 89
Other Investing Activities, net
0.00 30 12 1.00 -20 -20 -1.00 -19 1.00 -2.00 -13
Net Cash From Financing Activities
-418 -966 2,653 -1,794 2,534 -989 -339 -1,093 -1,510 -95 -1,393
Net Cash From Continuing Financing Activities
-418 -966 2,653 -1,794 2,534 -989 -339 -1,093 -1,510 -95 -1,393
Repayment of Debt
-1.00 -648 -34 -1,440 -24 -654 - -755 -1,034 249 -45
Payment of Dividends
-304 -305 -305 -305 -320 -321 -322 -321 -337 -337 -338
Other Financing Activities, net
-113 -14 -19 -49 -101 -14 -17 -17 -139 -7.00 -10
Effect of Exchange Rate Changes
-19 - - -32 20 37 1.00 10 -19 -14 -1.00

Annual Balance Sheets for Stryker

This table presents Stryker's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
16,223 20,435 22,197 27,229 30,167 34,330 34,631 36,884 39,912 42,971 47,844
Total Current Assets
7,943 7,861 7,993 9,733 11,058 9,707 10,017 10,275 12,518 14,847 14,755
Cash & Equivalents
3,379 3,316 2,542 3,616 4,337 2,943 2,944 1,844 2,971 3,652 4,011
Short-Term Investments
700 68 251 83 88 81 75 84 82 841 89
Accounts Receivable
1,662 1,967 2,198 2,332 2,893 2,701 3,022 3,565 3,765 3,987 4,039
Inventories, net
1,639 2,030 2,465 2,955 2,980 3,494 3,314 3,995 4,843 4,774 5,310
Prepaid Expenses
563 480 537 747 760 488 662 787 857 1,593 1,306
Plant, Property, & Equipment, net
1,199 1,569 1,975 2,291 2,567 2,752 2,833 2,970 3,215 3,448 3,876
Plant, Property & Equipment, gross
2,730 3,161 3,800 4,277 4,714 5,182 5,498 5,805 6,344 6,683 7,537
Accumulated Depreciation
1,531 1,592 1,825 1,986 2,147 2,430 2,665 2,835 3,129 3,235 3,661
Total Noncurrent Assets
7,081 11,005 12,229 15,205 16,542 21,871 21,781 23,639 24,179 24,676 29,213
Goodwill
4,136 6,356 7,168 8,563 9,069 12,778 12,918 14,880 15,243 15,855 19,291
Intangible Assets
1,794 3,508 3,477 4,163 4,227 5,554 4,840 4,885 4,593 4,395 5,681
Noncurrent Deferred & Refundable Income Taxes
- - 283 1,678 1,575 1,530 1,760 1,410 1,670 1,742 1,098
Other Noncurrent Operating Assets
1,151 1,141 1,301 801 1,671 2,009 2,263 2,464 2,673 2,684 3,143
Total Liabilities & Shareholders' Equity
16,223 20,435 22,197 27,229 30,167 34,330 34,631 36,884 39,912 42,971 47,844
Total Liabilities
7,712 10,885 12,217 15,499 17,360 21,246 19,754 20,268 21,319 22,337 25,424
Total Current Liabilities
3,502 3,148 3,485 4,807 4,400 5,041 4,549 6,303 7,921 7,616 7,794
Short-Term Debt
768 228 632 1,373 859 761 7.00 1,191 2,094 1,409 1,000
Accounts Payable
410 437 487 646 675 810 1,129 1,413 1,517 1,679 1,799
Dividends Payable
142 159 178 192 213 237 263 284 304 320 337
Current Deferred & Payable Income Tax Liabilities
141 40 143 158 171 207 192 292 391 539 418
Current Employee Benefit Liabilities
637 767 838 917 955 925 1,092 1,149 1,478 1,403 1,595
Other Current Liabilities
710 923 1,207 1,521 1,196 1,586 1,465 1,744 2,137 2,266 2,645
Total Noncurrent Liabilities
4,210 7,737 8,732 10,692 12,960 16,205 15,205 13,965 13,398 14,721 17,630
Long-Term Debt
3,230 6,686 6,590 8,486 10,231 13,230 12,472 11,857 10,901 12,188 14,859
Noncurrent Deferred Revenue
- 287 1,261 1,228 1,068 990 913 641 567 349 402
Other Noncurrent Operating Liabilities
980 764 881 978 1,661 1,985 1,820 1,467 1,930 2,184 2,369
Total Equity & Noncontrolling Interests
8,511 9,550 9,980 11,730 12,807 13,084 14,877 16,616 18,593 20,634 22,420
Total Preferred & Common Equity
8,511 9,550 9,966 11,730 12,807 13,084 14,877 16,616 18,593 20,634 22,420
Total Common Equity
8,511 9,550 9,966 11,730 12,807 13,084 14,877 16,616 18,593 20,634 22,420
Common Stock
1,358 1,469 1,533 1,596 1,665 1,779 1,928 2,072 2,238 2,399 2,635
Retained Earnings
7,792 8,842 8,986 10,765 11,748 12,462 13,480 14,765 16,771 18,528 20,472
Accumulated Other Comprehensive Income / (Loss)
-639 -761 -553 -631 -606 -1,157 -531 -221 -416 -293 -687

Quarterly Balance Sheets for Stryker

This table presents Stryker's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
39,912 39,402 39,130 43,833 42,971 46,006 46,331 47,057 46,291 47,930 47,247
Total Current Assets
12,518 11,892 11,645 14,673 14,847 13,022 13,003 13,711 13,338 14,418 14,183
Cash & Equivalents
2,971 2,330 1,874 3,850 3,652 2,320 2,375 3,256 2,878 3,391 3,271
Short-Term Investments
82 77 83 834 841 89 89 87 87 85 0.00
Accounts Receivable
3,765 3,473 3,622 3,736 3,987 3,961 3,918 3,643 3,571 3,743 3,693
Inventories, net
4,843 5,026 5,044 5,292 4,774 5,105 5,289 5,370 5,419 5,521 5,747
Prepaid Expenses
857 986 1,022 961 1,593 1,547 1,332 1,355 1,383 1,678 1,472
Plant, Property, & Equipment, net
3,215 3,260 3,318 3,429 3,448 3,536 3,702 3,734 3,887 3,958 4,054
Plant, Property & Equipment, gross
6,344 6,458 6,622 6,889 6,683 6,910 7,272 7,405 7,630 7,809 7,998
Accumulated Depreciation
3,129 3,198 3,304 3,460 3,235 3,374 3,570 3,671 3,743 3,851 3,944
Total Noncurrent Assets
24,179 24,250 24,167 25,731 24,676 29,448 29,626 29,612 29,066 29,554 29,010
Goodwill
15,243 15,351 15,408 16,396 15,855 19,089 19,183 19,256 19,188 19,584 19,326
Intangible Assets
4,593 4,509 4,363 4,940 4,395 6,132 5,962 5,845 5,516 5,742 5,542
Noncurrent Deferred & Refundable Income Taxes
1,670 1,641 1,606 1,562 1,742 1,411 1,375 1,374 1,193 994 901
Other Noncurrent Operating Assets
2,673 2,749 2,790 2,833 2,684 2,816 3,106 3,137 3,169 3,234 3,241
Total Liabilities & Shareholders' Equity
39,912 39,402 39,130 43,833 42,971 46,006 46,331 47,057 46,291 47,930 47,247
Total Liabilities
21,319 20,230 19,368 23,684 22,337 25,076 25,140 25,272 23,312 23,942 23,790
Total Current Liabilities
7,921 6,955 6,926 7,669 7,616 7,929 7,288 7,414 6,315 6,684 6,500
Short-Term Debt
2,094 2,058 2,095 2,159 1,409 2,398 1,751 1,750 499 750 754
Accounts Payable
1,517 1,246 1,304 1,337 1,679 1,464 1,442 1,498 1,592 1,663 1,634
Dividends Payable
304 305 305 305 320 320 321 321 337 338 335
Current Deferred & Payable Income Tax Liabilities
391 444 334 394 539 599 91 118 476 224 65
Current Employee Benefit Liabilities
1,478 778 887 1,250 1,403 919 1,075 1,306 885 1,105 1,363
Other Current Liabilities
2,137 2,124 2,001 2,224 2,266 2,229 2,608 2,421 2,526 2,604 2,349
Total Noncurrent Liabilities
13,398 13,275 12,442 16,015 14,721 17,147 17,852 17,858 16,997 17,258 17,290
Long-Term Debt
10,901 10,807 10,127 13,325 12,188 14,383 14,829 14,845 14,224 14,192 14,176
Noncurrent Deferred Revenue
567 565 350 368 349 372 395 400 403 406 413
Other Noncurrent Operating Liabilities
1,930 1,903 1,965 2,322 2,184 2,392 2,628 2,613 2,370 2,660 2,701
Total Equity & Noncontrolling Interests
18,593 19,172 19,762 20,149 20,634 20,930 21,191 21,785 22,979 23,988 23,457
Total Preferred & Common Equity
18,593 19,172 19,762 20,149 20,634 20,930 21,191 21,785 22,979 23,988 23,457
Total Common Equity
18,593 19,172 19,762 20,149 20,634 20,930 21,191 21,785 22,979 23,988 23,457
Common Stock
2,238 2,295 2,343 2,391 2,399 2,477 2,530 2,591 2,684 2,749 2,802
Retained Earnings
16,771 17,254 17,774 18,303 18,528 18,862 19,423 19,960 20,878 21,815 21,248
Accumulated Other Comprehensive Income / (Loss)
-416 -377 -355 -545 -293 -409 -762 -766 -583 -576 -593

Annual Metrics And Ratios for Stryker

This table displays calculated financial ratios and metrics derived from Stryker's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
2.80% 13.86% 9.88% 9.30% 9.43% -3.58% 19.21% 7.84% 11.11% 10.23% 11.16%
EBITDA Growth
38.62% 15.71% 9.65% 13.83% 8.48% -17.19% 18.26% 12.53% 27.71% -3.38% 27.53%
EBIT Growth
49.57% 10.72% 7.39% 14.20% 8.74% -23.73% 16.73% 17.62% 36.90% -4.93% 31.27%
NOPAT Growth
179.02% 20.81% -39.10% 236.88% -42.35% -17.53% 24.17% 10.54% 34.18% -5.62% 11.19%
Net Income Growth
179.42% 14.45% -38.07% 248.33% -41.37% -23.24% 24.70% 18.25% 34.22% -5.43% 8.45%
EPS Growth
182.09% 15.08% -38.39% 248.51% -41.33% -23.36% 24.05% 18.43% 33.71% -5.94% 8.25%
Operating Cash Flow Growth
-44.95% 95.21% -18.59% 67.42% -16.05% 49.57% -0.43% -19.58% 41.43% 14.31% 18.91%
Free Cash Flow Firm Growth
-16.21% -517.93% 92.42% 255.89% 82.13% -561.85% 169.93% -147.42% 374.20% -23.25% -148.50%
Invested Capital Growth
11.34% 54.44% 10.18% 23.96% 8.87% 23.38% 1.28% 13.90% 2.92% 4.23% 14.83%
Revenue Q/Q Growth
0.98% 4.06% 2.59% 2.45% 2.30% 0.92% 2.63% 2.79% 3.08% 2.83% 3.01%
EBITDA Q/Q Growth
8.28% 0.78% 3.01% 0.49% 9.80% -7.89% 3.19% 0.52% 10.90% -13.09% 41.00%
EBIT Q/Q Growth
9.53% -1.23% 3.05% 0.34% 12.22% -11.94% 3.92% 0.15% 14.50% -16.66% 53.46%
NOPAT Q/Q Growth
23.57% 1.54% -43.27% 184.69% -40.42% -4.93% 3.80% -4.34% 20.69% -15.46% 8.74%
Net Income Q/Q Growth
22.26% -0.72% -42.66% 187.46% -39.20% -8.94% 4.95% -4.03% 22.44% -16.63% 10.30%
EPS Q/Q Growth
23.13% -0.91% -42.74% 188.27% -39.25% -8.89% 4.83% -4.04% 22.40% -16.83% 10.38%
Operating Cash Flow Q/Q Growth
8.16% -4.73% 1.37% 16.36% -12.43% 18.09% -6.77% 0.11% 16.48% 10.50% 4.39%
Free Cash Flow Firm Q/Q Growth
22.11% -2.29% -216.62% -76.94% 489.19% -270.63% 163.13% 2.81% 39.08% 35.87% -8.21%
Invested Capital Q/Q Growth
-1.74% -0.46% -3.53% 20.31% 4.23% 26.71% 0.70% 0.11% -0.36% -3.83% -2.38%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
66.38% 66.26% 65.73% 65.72% 65.14% 63.11% 64.11% 62.76% 63.70% 63.91% 63.96%
EBITDA Margin
21.44% 21.78% 21.74% 22.64% 22.44% 19.27% 19.12% 19.95% 22.93% 20.10% 25.14%
Operating Margin
18.71% 19.21% 18.46% 18.65% 18.23% 15.49% 15.10% 15.40% 18.97% 16.33% 19.47%
EBIT Margin
17.44% 16.96% 16.58% 17.32% 17.21% 13.62% 13.33% 14.54% 17.92% 15.45% 20.39%
Profit (Net Income) Margin
14.47% 14.54% 8.20% 26.12% 13.99% 11.14% 11.66% 12.78% 15.44% 13.25% 12.92%
Tax Burden Percent
82.94% 85.74% 49.44% 150.81% 81.30% 81.83% 87.42% 87.89% 86.17% 85.71% 71.91%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 88.15%
Effective Tax Rate
17.06% 14.26% 50.56% -50.81% 18.70% 18.17% 12.58% 12.11% 13.83% 14.29% 28.09%
Return on Invested Capital (ROIC)
18.97% 17.10% 8.16% 23.42% 11.68% 8.27% 9.24% 9.49% 11.78% 10.74% 10.89%
ROIC Less NNEP Spread (ROIC-NNEP)
44.00% 5.48% 5.37% 18.44% 9.83% 5.84% 6.71% 8.18% 10.07% 9.02% 8.38%
Return on Net Nonoperating Assets (RNNOA)
-2.15% 1.14% 2.28% 9.31% 5.30% 4.08% 5.02% 5.48% 6.19% 4.52% 4.19%
Return on Equity (ROE)
16.82% 18.24% 10.45% 32.73% 16.98% 12.35% 14.26% 14.97% 17.98% 15.26% 15.08%
Cash Return on Invested Capital (CROIC)
8.24% -25.70% -1.53% 2.03% 3.19% -12.66% 7.96% -3.51% 8.90% 6.60% -2.92%
Operating Return on Assets (OROA)
10.36% 10.48% 9.68% 9.53% 8.93% 6.06% 6.62% 7.50% 9.57% 8.43% 11.28%
Return on Assets (ROA)
8.59% 8.99% 4.79% 14.38% 7.26% 4.96% 5.78% 6.59% 8.24% 7.22% 7.15%
Return on Common Equity (ROCE)
16.82% 18.24% 10.44% 32.71% 16.98% 12.35% 14.26% 14.97% 17.98% 15.26% 15.08%
Return on Equity Simple (ROE_SIMPLE)
16.91% 17.25% 10.23% 30.29% 16.26% 12.22% 13.40% 14.19% 17.02% 14.51% 0.00%
Net Operating Profit after Tax (NOPAT)
1,544 1,865 1,136 3,826 2,206 1,819 2,259 2,497 3,350 3,162 3,516
NOPAT Margin
15.52% 16.47% 9.13% 28.13% 14.82% 12.68% 13.20% 13.53% 16.34% 13.99% 14.00%
Net Nonoperating Expense Percent (NNEP)
-25.03% 11.61% 2.79% 4.98% 1.86% 2.43% 2.53% 1.31% 1.71% 1.72% 2.51%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 8.42% 10.61% 9.24% 9.18%
Cost of Revenue to Revenue
33.62% 33.74% 34.27% 34.28% 34.86% 36.89% 35.89% 37.24% 36.30% 36.09% 36.04%
SG&A Expenses to Revenue
36.30% 36.53% 36.58% 37.49% 35.99% 37.36% 37.57% 34.61% 34.69% 34.01% 34.44%
R&D to Revenue
6.28% 6.31% 6.32% 6.34% 6.52% 6.86% 7.22% 7.88% 6.77% 6.49% 6.46%
Operating Expenses to Revenue
47.67% 47.06% 47.28% 47.06% 46.92% 47.62% 49.01% 47.36% 44.74% 47.58% 44.50%
Earnings before Interest and Taxes (EBIT)
1,735 1,921 2,063 2,356 2,562 1,954 2,281 2,683 3,673 3,492 5,121
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,132 2,467 2,705 3,079 3,340 2,766 3,271 3,681 4,701 4,542 6,314
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.72 4.32 5.41 4.71 5.84 6.78 6.59 5.46 6.06 6.65 6.00
Price to Tangible Book Value (P/TBV)
12.26 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 357.44 0.00
Price to Revenue (P/Rev)
3.18 3.64 4.33 4.06 5.02 6.18 5.73 4.92 5.50 6.07 5.35
Price to Earnings (P/E)
21.98 25.03 52.85 15.54 35.89 55.45 49.20 38.47 35.62 45.86 41.41
Dividend Yield
1.68% 1.42% 1.21% 1.31% 1.07% 1.00% 0.99% 1.18% 1.03% 0.90% 0.97%
Earnings Yield
4.55% 4.00% 1.89% 6.44% 2.79% 1.80% 2.03% 2.60% 2.81% 2.18% 2.42%
Enterprise Value to Invested Capital (EV/IC)
3.68 3.38 4.00 3.39 4.14 4.10 4.37 3.63 4.25 4.87 4.23
Enterprise Value to Revenue (EV/Rev)
3.17 3.95 4.69 4.51 5.47 6.94 6.29 5.52 5.98 6.48 5.82
Enterprise Value to EBITDA (EV/EBITDA)
14.80 18.14 21.57 19.93 24.38 36.02 32.89 27.66 26.09 32.22 23.15
Enterprise Value to EBIT (EV/EBIT)
18.19 23.30 28.28 26.05 31.78 50.99 47.16 37.95 33.40 41.91 28.54
Enterprise Value to NOPAT (EV/NOPAT)
20.44 24.00 51.38 16.04 36.91 54.77 47.62 40.78 36.61 46.29 41.58
Enterprise Value to Operating Cash Flow (EV/OCF)
32.16 23.37 37.43 23.51 37.16 30.40 32.97 38.80 33.05 34.50 28.98
Enterprise Value to Free Cash Flow (EV/FCFF)
47.06 0.00 0.00 185.43 135.07 0.00 55.25 0.00 48.46 75.33 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.47 0.72 0.72 0.84 0.87 1.07 0.84 0.79 0.70 0.66 0.71
Long-Term Debt to Equity
0.38 0.70 0.66 0.72 0.80 1.01 0.84 0.71 0.59 0.59 0.66
Financial Leverage
-0.05 0.21 0.42 0.50 0.54 0.70 0.75 0.67 0.61 0.50 0.50
Leverage Ratio
1.96 2.03 2.18 2.28 2.34 2.49 2.47 2.27 2.18 2.11 2.11
Compound Leverage Factor
1.96 2.03 2.18 2.28 2.34 2.49 2.47 2.27 2.18 2.11 1.86
Debt to Total Capital
31.96% 41.99% 41.98% 45.67% 46.41% 51.68% 45.62% 43.99% 41.14% 39.72% 41.43%
Short-Term Debt to Total Capital
6.14% 1.38% 3.67% 6.36% 3.59% 2.81% 0.03% 4.02% 6.63% 4.12% 2.61%
Long-Term Debt to Total Capital
25.82% 40.61% 38.31% 39.31% 42.81% 48.86% 45.59% 39.97% 34.51% 35.61% 38.82%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.08% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
68.04% 58.01% 57.94% 54.33% 53.59% 48.33% 54.38% 56.01% 58.86% 60.28% 58.57%
Debt to EBITDA
1.88 2.80 2.67 3.20 3.32 5.06 3.82 3.54 2.76 2.99 2.51
Net Debt to EBITDA
-0.04 1.43 1.64 2.00 2.00 3.96 2.89 3.02 2.11 2.00 1.86
Long-Term Debt to EBITDA
1.52 2.71 2.44 2.76 3.06 4.78 3.81 3.22 2.32 2.68 2.35
Debt to NOPAT
2.59 3.71 6.36 2.58 5.03 7.69 5.52 5.23 3.88 4.30 4.51
Net Debt to NOPAT
-0.05 1.89 3.90 1.61 3.02 6.03 4.19 4.45 2.97 2.88 3.34
Long-Term Debt to NOPAT
2.09 3.59 5.80 2.22 4.64 7.27 5.52 4.75 3.25 3.85 4.23
Altman Z-Score
4.43 4.02 4.33 3.69 4.17 3.78 4.43 4.12 4.72 5.29 4.82
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.07% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.27 2.50 2.29 2.02 2.51 1.93 2.20 1.63 1.58 1.95 1.89
Quick Ratio
1.64 1.70 1.43 1.25 1.66 1.14 1.33 0.87 0.86 1.11 1.04
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
671 -2,802 -212 331 603 -2,784 1,947 -923 2,531 1,943 -942
Operating Cash Flow to CapEx
363.33% 390.82% 260.70% 456.29% 337.60% 672.90% 621.52% 446.26% 645.39% 561.85% 662.81%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.55
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.31
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.06
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.59 0.62 0.58 0.55 0.52 0.45 0.50 0.52 0.53 0.55 0.55
Accounts Receivable Turnover
6.15 6.24 5.98 6.00 5.70 5.13 5.98 5.60 5.59 5.83 6.26
Inventory Turnover
2.07 2.08 1.90 1.72 1.75 1.64 1.80 1.88 1.68 1.70 1.80
Fixed Asset Turnover
8.66 8.18 7.02 6.38 6.13 5.40 6.13 6.36 6.63 6.78 6.86
Accounts Payable Turnover
9.05 9.02 9.23 8.23 7.85 7.13 6.33 5.41 5.08 5.10 5.20
Days Sales Outstanding (DSO)
59.34 58.48 61.08 60.78 64.07 71.14 61.05 65.16 65.26 62.61 58.32
Days Inventory Outstanding (DIO)
176.11 175.24 192.39 212.13 208.78 223.18 202.36 194.13 216.79 215.22 203.33
Days Payable Outstanding (DPO)
40.33 40.45 39.55 44.34 46.47 51.19 57.63 67.52 71.87 71.52 70.13
Cash Conversion Cycle (CCC)
195.12 193.27 213.92 228.57 226.37 243.12 205.77 191.78 210.18 206.31 191.52
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
8,572 13,239 14,587 18,082 19,685 24,288 24,600 28,020 28,839 30,058 34,516
Invested Capital Turnover
1.22 1.04 0.89 0.83 0.79 0.65 0.70 0.70 0.72 0.77 0.78
Increase / (Decrease) in Invested Capital
873 4,667 1,348 3,495 1,603 4,603 312 3,420 819 1,219 4,458
Enterprise Value (EV)
31,552 44,752 58,346 61,369 81,414 99,632 107,567 101,822 122,665 146,361 146,169
Market Capitalization
31,633 41,222 53,903 55,209 74,749 88,665 98,107 90,702 112,723 137,257 134,410
Book Value per Share
$22.66 $25.50 $26.63 $31.35 $34.21 $34.82 $39.44 $43.91 $48.94 $54.13 $58.63
Tangible Book Value per Share
$6.87 ($0.84) ($1.81) ($2.66) ($1.31) ($13.97) ($7.64) ($8.32) ($3.27) $1.01 ($6.67)
Total Capital
12,509 16,464 17,202 21,589 23,897 27,075 27,356 29,664 31,588 34,231 38,279
Total Debt
3,998 6,914 7,222 9,859 11,090 13,991 12,479 13,048 12,995 13,597 15,859
Total Long-Term Debt
3,230 6,686 6,590 8,486 10,231 13,230 12,472 11,857 10,901 12,188 14,859
Net Debt
-81 3,530 4,429 6,160 6,665 10,967 9,460 11,120 9,942 9,104 11,759
Capital Expenditures (CapEx)
270 490 598 572 649 487 525 588 575 755 761
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,130 1,557 2,347 2,600 3,092 2,403 2,456 3,235 3,638 4,147 3,861
Debt-free Net Working Capital (DFNWC)
5,209 4,941 5,140 6,299 7,517 5,427 5,475 5,163 6,691 8,640 7,961
Net Working Capital (NWC)
4,441 4,713 4,508 4,926 6,658 4,666 5,468 3,972 4,597 7,231 6,961
Net Nonoperating Expense (NNE)
105 218 116 273 123 220 265 139 185 169 270
Net Nonoperating Obligations (NNO)
61 3,689 4,607 6,352 6,878 11,204 9,723 11,404 10,246 9,424 12,096
Total Depreciation and Amortization (D&A)
397 546 642 723 778 812 990 998 1,028 1,050 1,193
Debt-free, Cash-free Net Working Capital to Revenue
11.36% 13.75% 18.86% 19.12% 20.77% 16.74% 14.36% 17.53% 17.75% 18.35% 15.37%
Debt-free Net Working Capital to Revenue
52.37% 43.63% 41.31% 46.31% 50.50% 37.82% 32.00% 27.99% 32.64% 38.24% 31.70%
Net Working Capital to Revenue
44.65% 41.62% 36.23% 36.22% 44.73% 32.51% 31.96% 21.53% 22.43% 32.00% 27.72%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.82 $4.40 $2.73 $9.50 $5.57 $4.26 $5.29 $6.23 $8.34 $7.86 $8.49
Adjusted Weighted Average Basic Shares Outstanding
376.60M 374.10M 374M 374.10M 374M 375.50M 377M 378.20M 379.60M 381M 382.20M
Adjusted Diluted Earnings per Share
$3.78 $4.35 $2.68 $9.34 $5.48 $4.20 $5.21 $6.17 $8.25 $7.76 $8.40
Adjusted Weighted Average Diluted Shares Outstanding
380.90M 378.50M 380.10M 380.30M 379.90M 380.30M 382.30M 382.20M 383.70M 385.60M 386.50M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
372.98M 372.88M 374.64M 372.66M 374.58M 376.20M 377.54M 378.83M 380.26M 381.58M 382.69M
Normalized Net Operating Profit after Tax (NOPAT)
1,544 1,865 1,608 1,776 2,206 1,819 2,259 2,734 3,381 3,999 3,638
Normalized NOPAT Margin
15.52% 16.47% 12.92% 13.06% 14.82% 12.68% 13.20% 14.82% 16.50% 17.70% 14.48%
Pre Tax Income Margin
17.44% 16.96% 16.58% 17.32% 17.21% 13.62% 13.33% 14.54% 17.92% 15.45% 17.97%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.44
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.79
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.18
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.54
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
36.21% 34.49% 72.06% 20.18% 37.35% 53.97% 47.64% 44.57% 35.99% 40.73% 39.56%
Augmented Payout Ratio
84.85% 35.28% 94.61% 28.62% 52.09% 53.97% 47.64% 44.57% 35.99% 40.73% 39.56%

Quarterly Metrics And Ratios for Stryker

This table displays calculated financial ratios and metrics derived from Stryker's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 383,360,762.00 383,573,046.00 380,691,004.00
DEI Adjusted Shares Outstanding
- - - - - - - - 383,360,762.00 383,573,046.00 380,691,004.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 1.94 3.33 1.98
Growth Metrics
- - - - - - - - - - -
Revenue Growth
9.73% 8.53% 11.92% 10.68% 11.88% 11.07% 10.25% 11.42% 2.63% 9.42% 7.64%
EBITDA Growth
26.39% 8.46% 15.92% -46.34% -12.43% 4.46% 2.06% 118.82% 10.66% 36.03% -4.01%
EBIT Growth
35.94% 11.01% 20.02% -56.93% -17.23% 1.80% -1.34% 146.74% 10.77% 45.11% -3.88%
NOPAT Growth
29.49% 9.67% 17.02% -48.73% -13.66% 11.46% 9.21% 49.52% 14.50% 39.77% -17.58%
Net Income Growth
33.11% 11.79% 20.52% -52.23% -17.01% 7.15% 3.00% 55.49% 13.91% 44.34% -12.34%
EPS Growth
33.12% 10.88% 20.00% -52.68% -17.56% 7.01% 2.78% 56.03% 14.20% 44.10% -11.71%
Operating Cash Flow Growth
-54.16% -7.99% 40.38% 26.37% 22.55% 75.51% 4.48% 10.98% 132.40% 13.50% -5.13%
Free Cash Flow Firm Growth
-1,883.69% -166.92% -572.05% -275.17% -700.19% -1,139.34% -118.84% -475.82% 127.53% 127.49% 121.79%
Invested Capital Growth
5.09% 4.18% 7.98% 4.23% 19.00% 17.46% 13.13% 14.83% -1.54% 0.46% 0.26%
Revenue Q/Q Growth
-9.84% 3.41% 1.33% 17.15% -8.86% 2.66% 0.58% 18.39% -16.05% 9.45% -1.05%
EBITDA Q/Q Growth
-19.85% 6.17% 4.38% -39.59% 30.81% 26.64% 1.98% 96.41% -50.61% 54.16% -28.29%
EBIT Q/Q Growth
-24.71% 8.13% 4.51% -49.38% 44.70% 32.98% 1.28% 124.68% -56.83% 70.84% -33.14%
NOPAT Q/Q Growth
-29.19% 4.70% -0.14% -30.75% 19.25% 35.16% -2.16% -5.19% -8.67% 64.99% -42.30%
Net Income Q/Q Growth
-31.06% 4.70% 1.09% -34.53% 19.78% 35.17% -2.83% -1.16% -12.25% 71.28% -40.99%
EPS Q/Q Growth
-31.21% 4.39% 0.93% -34.72% 19.86% 35.50% -3.06% -0.90% -12.27% 70.98% -40.61%
Operating Cash Flow Q/Q Growth
-86.65% 210.29% 132.86% 31.00% -87.05% 344.40% 38.61% 39.16% -72.89% 117.04% 15.86%
Free Cash Flow Firm Q/Q Growth
-276.02% 43.79% -313.08% 57.14% -704.04% 12.93% 27.06% -12.77% 138.44% -13.07% -42.17%
Invested Capital Q/Q Growth
3.80% 1.33% 3.04% -3.83% 18.51% 0.02% -0.76% -2.38% 1.62% 2.05% -0.95%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
63.57% 63.00% 64.02% 64.85% 63.83% 63.78% 63.60% 64.54% 63.29% 68.27% 65.15%
EBITDA Margin
22.56% 23.16% 23.86% 12.31% 17.66% 21.79% 22.09% 36.65% 21.56% 30.37% 22.01%
Operating Margin
18.54% 19.38% 19.75% 9.03% 14.27% 18.48% 18.74% 25.16% 15.55% 25.18% 15.86%
EBIT Margin
17.60% 18.41% 18.98% 8.20% 13.02% 16.87% 16.99% 32.24% 16.58% 25.88% 17.48%
Profit (Net Income) Margin
15.03% 15.22% 15.18% 8.48% 11.15% 14.68% 14.18% 11.84% 12.38% 19.37% 11.55%
Tax Burden Percent
85.37% 82.67% 79.96% 103.41% 85.60% 87.01% 83.48% 49.79% 87.65% 81.59% 75.53%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 73.75% 85.17% 91.73% 87.46%
Effective Tax Rate
14.63% 17.33% 20.04% -3.41% 14.40% 12.99% 16.52% 50.21% 12.35% 18.41% 24.47%
Return on Invested Capital (ROIC)
11.36% 11.53% 11.53% 7.16% 8.65% 11.61% 11.45% 9.74% 9.74% 14.86% 8.90%
ROIC Less NNEP Spread (ROIC-NNEP)
10.98% 11.14% 11.23% 6.61% 8.16% 10.94% 10.73% 9.29% 9.18% 14.27% 8.68%
Return on Net Nonoperating Assets (RNNOA)
6.81% 6.70% 6.53% 3.31% 5.18% 6.68% 6.32% 4.64% 5.60% 8.29% 4.90%
Return on Equity (ROE)
18.17% 18.23% 18.06% 10.47% 13.83% 18.29% 17.77% 14.39% 15.34% 23.15% 13.80%
Cash Return on Invested Capital (CROIC)
7.15% 8.07% 4.75% 6.60% -8.05% -6.51% -2.61% -2.92% 11.79% 10.77% 10.60%
Operating Return on Assets (OROA)
9.68% 10.29% 10.19% 4.47% 7.08% 9.40% 9.11% 17.83% 9.08% 14.19% 9.75%
Return on Assets (ROA)
8.27% 8.50% 8.15% 4.63% 6.06% 8.18% 7.61% 6.55% 6.78% 10.62% 6.44%
Return on Common Equity (ROCE)
18.17% 18.23% 18.06% 10.47% 13.83% 18.29% 17.77% 14.39% 15.34% 23.15% 13.80%
Return on Equity Simple (ROE_SIMPLE)
17.53% 17.45% 17.82% 0.00% 13.66% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
830 869 868 601 716 968 947 898 820 1,354 781
NOPAT Margin
15.83% 16.02% 15.79% 9.34% 12.21% 16.08% 15.64% 12.53% 13.63% 20.54% 11.98%
Net Nonoperating Expense Percent (NNEP)
0.37% 0.39% 0.30% 0.56% 0.49% 0.68% 0.72% 0.46% 0.56% 0.59% 0.22%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.76% 1.90% 2.56% 2.47% 2.35% 2.18% 3.48% 2.03%
Cost of Revenue to Revenue
36.43% 37.00% 35.98% 35.15% 36.17% 36.22% 36.40% 35.46% 36.71% 31.73% 34.85%
SG&A Expenses to Revenue
35.09% 34.06% 34.51% 32.66% 39.21% 34.52% 33.76% 31.06% 37.89% 33.83% 35.48%
R&D to Revenue
7.02% 6.69% 6.86% 5.56% 6.90% 6.76% 6.77% 5.59% 6.86% 6.59% 6.64%
Operating Expenses to Revenue
45.03% 43.62% 44.27% 55.83% 49.56% 45.30% 44.86% 39.38% 47.74% 43.09% 49.29%
Earnings before Interest and Taxes (EBIT)
923 998 1,043 528 764 1,016 1,029 2,312 998 1,705 1,140
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,183 1,256 1,311 792 1,036 1,312 1,338 2,628 1,298 2,001 1,435
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
7.07 6.56 6.83 6.65 6.79 7.13 6.49 6.00 5.47 5.03 4.50
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 357.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
6.47 6.06 6.27 6.07 6.12 6.35 5.80 5.35 4.98 4.67 4.02
Price to Earnings (P/E)
40.36 37.59 38.35 45.86 49.68 51.81 48.02 41.41 37.68 32.37 29.16
Dividend Yield
0.87% 0.93% 0.89% 0.90% 0.88% 0.84% 0.91% 0.97% 1.05% 1.11% 1.28%
Earnings Yield
2.48% 2.66% 2.61% 2.18% 2.01% 1.93% 2.08% 2.42% 2.65% 3.09% 3.43%
Enterprise Value to Invested Capital (EV/IC)
4.88 4.61 4.75 4.87 4.39 4.64 4.37 4.23 3.92 3.69 3.31
Enterprise Value to Revenue (EV/Rev)
6.97 6.54 6.76 6.48 6.74 6.94 6.34 5.82 5.44 5.12 4.46
Enterprise Value to EBITDA (EV/EBITDA)
29.53 27.72 28.41 32.22 35.59 37.14 34.52 23.15 21.36 18.96 16.98
Enterprise Value to EBIT (EV/EBIT)
37.30 34.83 35.43 41.91 46.93 49.33 46.32 28.54 26.35 22.99 20.57
Enterprise Value to NOPAT (EV/NOPAT)
41.27 38.69 39.70 46.29 51.31 52.50 47.81 41.58 38.00 32.97 30.49
Enterprise Value to Operating Cash Flow (EV/OCF)
42.10 40.96 38.67 34.50 36.48 34.69 31.99 28.98 25.58 23.92 21.54
Enterprise Value to Free Cash Flow (EV/FCFF)
69.95 58.35 103.83 75.33 0.00 0.00 0.00 0.00 33.00 34.38 31.24
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.67 0.62 0.77 0.66 0.80 0.78 0.76 0.71 0.64 0.62 0.64
Long-Term Debt to Equity
0.56 0.51 0.66 0.59 0.69 0.70 0.68 0.66 0.62 0.59 0.60
Financial Leverage
0.62 0.60 0.58 0.50 0.63 0.61 0.59 0.50 0.61 0.58 0.57
Leverage Ratio
2.11 2.06 2.15 2.11 2.13 2.09 2.17 2.11 2.10 2.09 2.08
Compound Leverage Factor
2.11 2.06 2.15 2.11 2.13 2.09 2.17 1.56 1.79 1.91 1.82
Debt to Total Capital
40.16% 38.21% 43.45% 39.72% 44.50% 43.90% 43.24% 41.43% 39.05% 38.38% 38.89%
Short-Term Debt to Total Capital
6.42% 6.55% 6.06% 4.12% 6.36% 4.64% 4.56% 2.61% 1.32% 1.93% 1.96%
Long-Term Debt to Total Capital
33.73% 31.66% 37.40% 35.61% 38.14% 39.26% 38.68% 38.82% 37.73% 36.46% 36.93%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
59.84% 61.79% 56.55% 60.28% 55.50% 56.10% 56.76% 58.57% 60.95% 61.62% 61.11%
Debt to EBITDA
2.60 2.42 2.96 2.99 3.82 3.73 3.71 2.51 2.29 2.14 2.16
Net Debt to EBITDA
2.11 2.03 2.07 2.00 3.27 3.17 2.96 1.86 1.83 1.65 1.69
Long-Term Debt to EBITDA
2.18 2.01 2.55 2.68 3.27 3.33 3.32 2.35 2.21 2.04 2.05
Debt to NOPAT
3.63 3.38 4.14 4.30 5.50 5.27 5.13 4.51 4.07 3.73 3.88
Net Debt to NOPAT
2.95 2.84 2.89 2.88 4.71 4.48 4.10 3.34 3.25 2.86 3.03
Long-Term Debt to NOPAT
3.05 2.80 3.56 3.85 4.72 4.71 4.59 4.23 3.93 3.54 3.68
Altman Z-Score
5.40 5.43 4.84 5.06 4.67 4.93 4.70 4.63 4.67 4.51 4.13
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.71 1.68 1.91 1.95 1.64 1.78 1.85 1.89 2.11 2.16 2.18
Quick Ratio
0.85 0.81 1.10 1.11 0.80 0.88 0.94 1.04 1.04 1.08 1.07
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-621 -349 -1,442 -618 -4,971 -4,328 -3,157 -3,560 1,368 1,190 688
Operating Cash Flow to CapEx
122.16% 416.45% 867.06% 725.94% 203.25% 607.10% 823.53% 799.63% 350.00% 624.26% 616.46%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.25 8.44 4.81
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.93 8.94 10.22
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.80 7.51 8.56
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.55 0.56 0.54 0.55 0.54 0.56 0.54 0.55 0.55 0.55 0.56
Accounts Receivable Turnover
6.27 6.22 6.27 5.83 6.25 6.32 6.61 6.26 6.71 6.75 7.17
Inventory Turnover
1.62 1.61 1.57 1.70 1.65 1.65 1.65 1.80 1.74 1.67 1.64
Fixed Asset Turnover
6.66 6.68 6.73 6.78 6.83 6.79 6.81 6.86 6.81 6.75 6.75
Accounts Payable Turnover
5.81 5.92 6.08 5.10 6.17 6.22 6.19 5.20 5.98 5.83 5.82
Days Sales Outstanding (DSO)
58.22 58.73 58.24 62.61 58.43 57.77 55.23 58.32 54.40 54.11 50.91
Days Inventory Outstanding (DIO)
225.09 226.09 231.97 215.22 220.98 220.76 221.87 203.33 210.16 218.02 222.56
Days Payable Outstanding (DPO)
62.82 61.70 60.03 71.52 59.11 58.67 59.00 70.13 61.03 62.62 62.70
Cash Conversion Cycle (CCC)
220.50 223.12 230.18 206.31 220.30 219.87 218.11 191.52 203.53 209.51 210.76
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
29,935 30,332 31,254 30,058 35,622 35,628 35,358 34,516 35,074 35,792 35,451
Invested Capital Turnover
0.72 0.72 0.73 0.77 0.71 0.72 0.73 0.78 0.71 0.72 0.74
Increase / (Decrease) in Invested Capital
1,451 1,218 2,310 1,219 5,687 5,296 4,104 4,458 -548 164 93
Enterprise Value (EV)
146,092 139,883 148,467 146,361 156,415 165,312 154,580 146,169 137,506 132,163 117,291
Market Capitalization
135,634 129,618 137,667 137,257 142,043 151,196 141,328 134,410 125,748 120,697 105,632
Book Value per Share
$50.40 $51.88 $52.87 $54.13 $54.85 $55.45 $56.98 $58.63 $60.05 $62.57 $61.15
Tangible Book Value per Share
($1.81) ($0.02) ($3.11) $1.01 ($11.25) ($10.35) ($8.67) ($6.67) ($4.51) ($3.49) ($3.68)
Total Capital
32,037 31,984 35,633 34,231 37,711 37,771 38,380 38,279 37,702 38,930 38,387
Total Debt
12,865 12,222 15,484 13,597 16,781 16,580 16,595 15,859 14,723 14,942 14,930
Total Long-Term Debt
10,807 10,127 13,325 12,188 14,383 14,829 14,845 14,859 14,224 14,192 14,176
Net Debt
10,458 10,265 10,800 9,104 14,372 14,116 13,252 11,759 11,758 11,466 11,659
Capital Expenditures (CapEx)
167 152 170 266 123 183 187 268 166 202 237
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4,588 4,857 4,479 4,147 5,082 5,002 4,704 3,861 4,557 5,008 5,166
Debt-free Net Working Capital (DFNWC)
6,995 6,814 9,163 8,640 7,491 7,466 8,047 7,961 7,522 8,484 8,437
Net Working Capital (NWC)
4,937 4,719 7,004 7,231 5,093 5,715 6,297 6,961 7,023 7,734 7,683
Net Nonoperating Expense (NNE)
42 44 34 55 62 84 88 49 75 78 28
Net Nonoperating Obligations (NNO)
10,763 10,570 11,105 9,424 14,692 14,437 13,573 12,096 12,095 11,804 11,994
Total Depreciation and Amortization (D&A)
260 258 268 264 272 296 309 316 300 296 295
Debt-free, Cash-free Net Working Capital to Revenue
21.89% 22.71% 20.38% 18.35% 21.89% 21.00% 19.29% 15.37% 18.03% 19.38% 19.64%
Debt-free Net Working Capital to Revenue
33.37% 31.86% 41.70% 38.24% 32.26% 31.35% 33.01% 31.70% 29.77% 32.84% 32.08%
Net Working Capital to Revenue
23.55% 22.06% 31.87% 32.00% 21.94% 23.99% 25.83% 27.72% 27.79% 29.93% 29.21%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.07 $2.17 $2.18 $1.44 $1.71 $2.32 $2.25 $2.21 $1.95 $3.32 $1.97
Adjusted Weighted Average Basic Shares Outstanding
380.40M 381M 381.10M 381M 381.70M 382.20M 382.40M 382.20M 382.90M 383.50M 382.20M
Adjusted Diluted Earnings per Share
$2.05 $2.14 $2.16 $1.41 $1.69 $2.29 $2.22 $2.20 $1.93 $3.30 $1.96
Adjusted Weighted Average Diluted Shares Outstanding
385.10M 385.40M 385.60M 385.60M 386.40M 386.40M 386.70M 386.50M 386.50M 386M 384.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
380.95M 381.08M 381.22M 381.58M 382.16M 382.31M 382.42M 382.69M 383.36M 383.57M 380.69M
Normalized Net Operating Profit after Tax (NOPAT)
830 869 868 407 746 1,016 1,008 1,268 820 1,354 1,002
Normalized NOPAT Margin
15.83% 16.02% 15.79% 6.32% 12.73% 16.88% 16.65% 17.68% 13.63% 20.55% 15.37%
Pre Tax Income Margin
17.60% 18.41% 18.98% 8.20% 13.02% 16.87% 16.99% 23.78% 14.12% 23.74% 15.29%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.74 12.09 7.97
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.54 9.60 5.46
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.62 10.66 6.31
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.42 8.17 3.80
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
34.48% 34.19% 33.40% 40.73% 43.20% 42.87% 43.09% 39.56% 38.99% 35.32% 36.79%
Augmented Payout Ratio
34.48% 34.19% 33.40% 40.73% 43.20% 42.87% 43.09% 39.56% 38.99% 35.32% 36.79%

Financials Breakdown Chart

Key Financial Trends

Stryker’s latest results show accelerating growth and stronger profitability. In Q2 2026, revenue increased to $6.59 billion, up approximately 9.4% from $6.02 billion in Q1 2026 and 9.4% from Q2 2025. Net income rose to $1.28 billion, compared with $745 million in Q1 and $884 million in the year-ago quarter. Diluted earnings per share increased to $3.30, versus $1.93 in Q1 2026 and $2.14 in Q2 2025.

Profitability also improved considerably. Q2 gross profit was $4.50 billion, representing a gross margin of approximately 68.3%, compared with 63.3% in Q1 2026 and 63.8% in Q2 2025. Operating income increased to $1.66 billion, producing an operating margin of approximately 25.2%. This compares with 15.5% in Q1 2026 and 18.5% in Q2 2025. The improvement came despite research and development spending rising to $434 million, while selling, general and administrative costs declined modestly from Q1.

The broader trend remains favorable. Comparing Q2 2026 with Q2 2023, revenue has grown from $5.00 billion to $6.59 billion, while net income has increased from $738 million to $1.28 billion. Diluted EPS rose from $1.93 to $3.30 over the same comparison. Dividend payments per share also increased from $0.75 in Q2 2023 to $0.88 in Q2 2026.

Stryker is generating substantial cash, although acquisitions continue to consume capital. Operating cash flow was $1.26 billion in Q2 2026, up from $1.11 billion in Q2 2025 and $688 million in Q2 2023. After $202 million of capital expenditures, the company produced an approximate quarterly free cash flow of $1.06 billion. Cash increased by $513 million during Q2, reversing the $1.13 billion decline recorded in Q1.

The balance sheet has expanded alongside the business. Total assets reached $47.93 billion at June 30, 2026, compared with $39.13 billion at June 30, 2024. Cash and equivalents increased to $3.39 billion from $1.87 billion over that period. However, total debt of approximately $15.17 billion remains significant, and goodwill plus intangible assets totaled approximately $25.33 billion, or more than half of total assets.

  • Accelerating revenue growth: Q2 2026 revenue increased approximately 9.4% year over year and reached a record level in the provided data.
  • Sharp margin expansion: Gross margin improved to approximately 68.3%, while operating margin reached approximately 25.2% in Q2 2026.
  • Strong earnings growth: Q2 net income increased approximately 44% year over year, and diluted EPS rose approximately 54% from Q2 2025.
  • Improving cash generation: Operating cash flow increased approximately 14% year over year, with estimated quarterly free cash flow exceeding $1 billion.
  • Growing liquidity: Cash and equivalents rose to $3.39 billion at the end of Q2, up from $2.88 billion at the end of Q1 2026.
  • Consistent shareholder returns: The quarterly dividend increased to $0.88 per share from $0.75 in Q2 2023, while dividend payments remain well covered by operating cash flow.
  • Acquisition-led expansion: Stryker spent $437 million on acquisitions in Q2 2026 and $4.75 billion in Q1 2025. These investments can support future growth, but their returns will need to be monitored.
  • Balance-sheet growth: Total assets and shareholders’ equity have increased steadily since 2023, reflecting business expansion and retained earnings accumulation.
  • Meaningful leverage: Total debt remains approximately $15.17 billion, and interest expense was $141 million in Q2 2026.
  • High acquisition-related asset exposure: Goodwill and intangible assets totaled approximately $25.3 billion, increasing the potential impact of future impairments if acquired businesses underperform.

Overall, the statements point to a stronger operating profile for Stryker, characterized by rising sales, expanding margins, improving EPS and healthy operating cash flow. Investors should nevertheless continue monitoring debt levels, acquisition returns and the company’s large goodwill and intangible asset balances.

11/16/26 08:52 PM ETAI Generated. May Contain Errors.

Stryker Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Stryker's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Stryker's net income appears to be on an upward trend, with a most recent value of $3.25 billion in 2025, rising from $1.44 billion in 2015. The previous period was $2.99 billion in 2024. Find out what analysts predict for Stryker in the coming months.

Stryker's total operating income in 2025 was $4.89 billion, based on the following breakdown:
  • Total Gross Profit: $16.07 billion
  • Total Operating Expenses: $11.18 billion

Over the last 10 years, Stryker's total revenue changed from $9.95 billion in 2015 to $25.12 billion in 2025, a change of 152.5%.

In the past 11 quarters, Stryker's cash and equivalents has ranged from $1.87 billion in Q2 2024 to $3.85 billion in Q3 2024, and is currently $3.27 billion as of their latest financial filing in Q3 2026.

Stryker had total debt of $15.86 billion at the end of 2025, a 16.6% increase from 2024, and a 296.7% increase since 2015.

Over the last 10 years, Stryker's book value per share changed from 22.66 in 2015 to 58.63 in 2025, a change of 158.7%.



Financial statements for NYSE:SYK last updated on 10/30/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners